Pfizer's experimental drug misses main goal of lung cancer trial
Pfizer's experimental drug misses main goal of lung cancer trial June 22 (Reuters) - Pfizer PFE.N said on Monday its drug for a type of lung cancer missed the main goal of a late-stage trial.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
Recent news on Pfizer
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials